Company: PCRX
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001628280-25-050176
Chunk: 62

Company: Pacira BioSciences, Inc.
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 62
---
 the present value of estimated future cash flows. Considerable management judgment is necessary to evaluate the impact of operating and macroeconomic changes and to estimate the future cash flows used to assume fair value. The Company’s estimates of future cash flows consider past performance, current and anticipated market conditions, internal projections and operating plans which incorporate estimates for sales growth and future margins. Additional assumptions include forecasted growth rates, estimated discount rates and the probability of success for the Company’s product pipeline candidate products. The assumptions also reflect current and anticipated market conditions and are consistent with those that would be used by other marketplace participants for similar valuation purposes. Such assumptions are subject to change due to changing economic and competitive conditions. The conclusion of the income approach as of September, 30, 2024 resulted in the carrying value of the Company exceeding its fair value by more than the goodwill balance. As a result, the then-goodwill balance of $163.2 million was fully impaired during the three months ended September 30, 2024. 

Pacira BioSciences, Inc.  |  Q3 2025 Form 10-Q  |  16

Intangible AssetsIntangible assets, net, consists of the IPR&D from the GQ Bio Acquisition and Flexion Acquisition, developed technology from the Flexion Acquisition and MyoScience Acquisition and customer relationships from the MyoScience Acquisition are summarized as follows (dollar amounts in thousands):September 30, 2025Gross Carrying ValueForeign Currency AdjustmentsAccumulated AmortizationIntangible Assets, NetWeighted-Average Useful LivesDeveloped technologies$590,000 $— $(241,893)$348,107 10 years, 5 monthsCustomer relationships90 — (58)32 10 yearsTotal finite-lived intangible assets, net590,090 — (241,951)348,139 Acquired IPR&D31,500 2,757 — 34,257      Total intangible assets, net$621,590 $2,757 $(241,951)$382,396 December 31, 2024Gross Carrying ValueAccumulated AmortizationIntangible Assets, NetWeighted-Average Useful LivesDeveloped technologies$590,000 $(198,934)$391,066 10 years, 5 monthsCustomer relationships90 (52)38 10 years     Total finite-lived intangible assets, net590,090 (198,986